XTX Topco’s Royalty Pharma RPRX Stock Holding History

XTX Topco’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243K	Buy	+4,330	New	+$225K	﹤0.01%	3093
2025 Q4	–	Sell	-145,144	Closed	-$5.12M	–	3722
2025 Q3	$5.12M	Buy	+145,144	New	+$5.25M	0.27%	27
2025 Q2	–	Sell	-53,119	Closed	-$1.65M	–	3045
2025 Q1	$1.65M	Buy	+53,119	New	+$1.68M	0.08%	320
2023 Q3	–	Sell	-20,911	Closed	-$643K	–	1947
2023 Q2	$643K	Buy	20,911 +11,636	+125%	+$394K	0.12%	238
2023 Q1	$334K	Sell	9,275 -2,971	-24%	-$110K	0.07%	568
2022 Q4	$484K	Buy	12,246 +6,049	+98%	+$252K	0.1%	313
2022 Q3	$249K	Buy	+6,197	New	+$265K	0.06%	624
2022 Q1	–	Sell	-10,280	Closed	-$410K	–	913
2021 Q4	$410K	Buy	+10,280	New	+$399K	0.23%	109

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco's RPRX Position: Q2 2026 in Review

XTX Topco opened a new position in Royalty Pharma (RPRX) in Q2 2026: 4,330 shares worth $243K. The stake represents ﹤0.01% of the portfolio and ranks #3093 among its holdings. This is a return to the name: XTX Topco previously reported a position in RPRX as recently as Q3 2025.

XTX Topco first reported a position in RPRX in Q4 2021 and has held it in 8 quarters since. The position peaked at $5.12M in Q3 2025. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

XTX Topco held 4,330 shares of Royalty Pharma worth $243K as of Q2 2026.
Royalty Pharma was a new XTX Topco position in Q2 2026.
Royalty Pharma made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3093 holding.
XTX Topco first reported a position in Royalty Pharma in Q4 2021 and has held it in 8 quarters since.
XTX Topco's Royalty Pharma position peaked at $5.12M in Q3 2025.
646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.